Abstract
We studied surveillance, incidence and outcome of viral infections in children undergoing allogeneic hematopoietic cell transplantation (HCT) in the main pediatric transplant units in Spain. We prospectively collected data from first year post-HCT in every consecutive allogeneic HCT performed during 3 years (N=215): first HCT=188 and second HCT=27; median age=6.6 years (0.1–20.7). Most patients had acute leukemia (N=137) and 135 recipients (63%) were CMV seropositive. A total of 46 patients underwent cord blood transplant, 133 patients underwent HCT from alternative donors (62%) and 101 patients received anti-thymocyte globulin. Observational time was completed in 137 patients, whereas the remaining 78 died after a median survival time of 99 days (3–352). CMV was monitored in all patients; adenovirus (ADV) and human herpesvirus 6 (HHV-6) were monitored in 101 and 33 patients, respectively. We found 145 viral infections in 103 patients: CMV (n=42), ADV (n=32), HHV-6 (n=7), polyomavirus (n=20), EBV (n=6), VZV (n=17) and others (n=8). CMV infection was significantly higher in seropositive patients (25 vs 7%) (P=0.02). Extensive chronic GVHD (cGVHD) was significantly associated with an increased rate of viral infections (12 of 16 patients with cGVHD had infections vs 91 of 199 without GVHD) (P=0.035). In total, 10 patients (4.6%) died of viral infections (CMV=5, ADV=3, respiratory=2). We found a high incidence of viral infection, but mortality was low.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kontoyiannis DP, Lewis RE, Marr K . The burden of bacterial and viral infections in hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2009; 15: 128–133.
Van Burik II JA, Carter SL, Friefield AG, High KP, Godder KT, Papanicolaou GA et al. Higher risk of Cytomegalovirus and aspergillus infections in recipients of T-cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease. Biol Blood Marrow Transplant 2007; 13: 1487–1498.
Feuchtinger T, Richard C, Pfeiffer M, Neuhäuser F, Lücke J, Handgretinger R et al. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. Klin Padiatr 2005; 217: 339–344.
Anderson EJ, Guzman-Cottrill JA, Kletzel M, Thormann K, Sullivan C, Zheng X et al. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. Pediatr Transplant 2008; 12: 219–227.
Van Tol MJD, Kroes ACM, Schinkel J, Dinkelaar W, Claas ECJ, Jol-van der Zijde CM et al. Adenovirus infection in pediatric stem cell transplant recipients: increased risk in young children with delayed immune recovery. Bone Marrow Transplant 2005; 36: 39–50.
Ogata M, Ogata M, Kikuchi H, Satou T, Kawano R, Ikewaki J et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 2006; 193: 68–79.
Guiraud G, Bogdanovic G, Priftakis P, Remberger M, Svahn BM, Barkholt L et al. The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica 2006; 91: 401–404.
Cesaro S, Facchin C, Tridello G, Messina C, Calore E, Biasolo MA et al. A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 363–370.
Kalpoe JS, van der Heiden PL, Barge RM, Houtzager S, Lankester AC, van Tol MJ et al. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning. Eur J Haematol 2007; 78: 314–321.
Przepiorka D, Weisdorf D, Martin P, Klingemann H-G, Beatty P, Hows J et al. Consensus conference on acute GVHD grading. Transplant 1995; 15: 825–828.
Ljungman P, Perez-Bercoff L, Jonsson J, Avetisyan G, Sparrelid E, Aschan J et al. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Haematologica 2006; 91: 78–83.
Yusuf U, Hale GA, Carr J, Gu Z, Benaim E, Woodard P et al. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 2006; 81: 1398–1404.
Erard V, Huang ML, Ferrenberg J, Nguy L, Stevens-Ayers TL, Hackman RC et al. Quantitative real-time polymerase chain reaction for detection of adenovirus after T-cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease. Clin Infect Dis 2007; 45: 958–965.
Savolainen H, Lautenschlager I, Piiparinen H, Saarinen-Pihkala U, Hovi L, Vettenranta K . Human herpesvirus-6 and -7 in pediatric stem cell transplantation. Pediatr Blood Cancer 2005; 45: 820–825.
De Patger PJA, Schuurman R, Visscher H, De Vos Ml, Bierings M, van Loon A M et al. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome biology of blood and marrow. Transplantation 2008; 14: 831–839.
Comoli P, Basso S, Zecca M, Pagliara D, Baldanti F, Bernardo ME et al. Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. Am J Transplant 2007; 7: 1648–1655.
Safdar A, Rodriguez GH, De Lima MJ, Petropoulos D, Chemaly RF, Worth LL et al. Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005. Medicine (Baltimore) 2007; 86: 324–333.
Fernández-Sanmartiín M, Izquierdo M, Fernández-Navarro JM, Verdeguer A, Castel V . Cidofovir in children after allogeneic stem cell transplantation. Bone Marrow Transpl 2004; 33 (Suppl 1): 231–232.
Myers GD, Bollard CM, Wu MF, Weiss H, Rooney CM, Heslop HE et al. Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39: 677–686.
Kampmann B, Cubitt D, Naik P, Walls T, Depala M, Samarasinghe S et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 2005; 130: 595–603.
Malker CM, van Burik JA, De For TE, Weisdorf DJ . Cytolegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biol Blood Marrow Transplant 2007; 13: 1106–1115.
Bordon V, Bravo S, Van Renterghem L, de Moerloose B, Benoit Y, Laureys G et al. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease. Transplant Infect Dis 2008; 10: 19–23.
Benjamin Jr DK, Miller WC, Bayliff S, Martel L, Alexander KA, Martin PL . Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J 2002; 21: 227–234.
Van Burik JA, Brunstein CG . Infectious complications following unrelated cord blood transplantation. Vox Sang 2007; 92: 289–296.
Barker JN, Hough RE, van Burik JA, DeFor TE, MacMillan ML, O’Brien MR et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant 2005; 11: 362–370.
Robin M, Marque-Juillet S, Scieux C, Peffault de Latour R, Ferry C, Rocha V et al. Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome. Haematologica 2007; 92: 1254–1257.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Verdeguer, A., de Heredia, C., González, M. et al. Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience. Bone Marrow Transplant 46, 119–124 (2011). https://doi.org/10.1038/bmt.2010.52
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.52
Keywords
This article is cited by
-
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
Nature Communications (2024)
-
Virus-Specific T Cells for Hematopoietic Stem Cell Transplantation
Current Stem Cell Reports (2017)
-
Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings
Annals of Hematology (2015)
-
Prospective, comprehensive, and effective viral monitoring in Cuban children undergoing solid organ transplantation
SpringerPlus (2014)
-
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant
Molecular Therapy (2013)